Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
99
100
Next >
Stock Market Hits A Wall Despite Booming Nvidia: Weekly Review
May 24, 2024
The Nasdaq and S&P 500 hit record highs, but fell back.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Jim Cramer Says This Basic Materials Stock Is 'Too Dicey,' Shares His Take On Arista Networks
May 24, 2024
"All of these stocks are a little volatile right now, but I think you want to own it and buy it into the volatility," Jim Cramer says.
Via
Benzinga
Stocks to Buy: 7 Undeniable Dow Darlings to Pile Into Now
May 24, 2024
Most Dow stocks are strong investments but these 7 stand out at the moment as the macroenvironment trends positive again.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
7 Stocks to Buy if the Market Ends Up Plunging
May 24, 2024
If the bears finally catch up to the bulls and take them down, these are the proven stocks to buy if the market falls.
Via
InvestorPlace
Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster
May 23, 2024
This winner can't stop winning.
Via
The Motley Fool
Here's How Much $100 Invested In Eli Lilly and Co 5 Years Ago Would Be Worth Today
May 20, 2024
Via
Benzinga
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next
May 23, 2024
Weight loss drugs get the new parody treatment in a "South Park" streaming special.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Bonds Break Down And Send Everyone To Cash
May 23, 2024
This situation is where the danger, the opportunity, and the action are right now.
Via
Talk Markets
3 Biotech Stocks to Buy on the Dip: May 2024
May 23, 2024
These biotech giants offer investors the best opportunity money can buy for excellent profits and returns this year.
Via
InvestorPlace
8 Health Care Stocks Whale Activity In Today's Session
May 23, 2024
Via
Benzinga
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study
May 23, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study
May 23, 2024
Via
CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
3 Blue Chip Stocks That You Can Buy and Hold for Years
May 23, 2024
You won't be taking on much risk by investing in these stalwarts.
Via
The Motley Fool
Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.
May 23, 2024
The search for the next GLP-1 drugs that will be blockbuster winners during the next market cycle is on, and here are three contenders.
Via
InvestorPlace
Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns
May 22, 2024
Compounding weight loss drugs, which are similar to brand-name medications such as Ozempic and Mounjaro, will be banned in Australia.
Via
Benzinga
The 500 Top Stocks to Buy in May, According to AI
May 22, 2024
MarketMaster AI tells us that the top stocks to buy in May represent high-quality companies with strong fundamentals.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Retire Rich: 3 Game-Changing Stocks to Own for the Next 10 Years
May 22, 2024
Here are three game-changing retirement stocks to own for the long-term, for those looking to create meaningful long-term wealth.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21, 2024
The Structure Therapeutics stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a significant upside potential.
Via
Benzinga
Tesla's Fall From Grace: Down 55% From Its Peak
May 21, 2024
There was a time when Tesla was the Nvidia of its day. Its stock did nothing but go up, and its earnings calls were intensely anticipated. For a full 30 months now, Tesla is down 55% from its peak.
Via
Talk Markets
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
May 21, 2024
Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and call it a day."
Via
Benzinga
Topics
ETFs
3 Growth Stocks That Could Be Millionaire-Makers: May Edition
May 21, 2024
Investors wanting to get rich should consider a long-term holding in these stocks, each of which has risen exponentially in the last year.
Via
InvestorPlace
Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You
May 21, 2024
Nestlé SA launches Vital Pursuit, a new food line tailored for GLP-1 weight loss medication users, featuring protein, fiber, and essential nutrients. Available Q4 nationwide.
Via
Benzinga
If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today
May 21, 2024
Have Eli Lilly's successes translated into stock performance?
Via
The Motley Fool
7 Reliable Blue-Chip Stocks That Cannot Miss
May 21, 2024
These reliable blue-chip stocks to own are the closest thing to slam dunk investments that exist. Discover why you should buy them now.
Via
InvestorPlace
Eli Lilly Secures China Nod For Popular Weight Loss/Diabetes Drug Tirzepatide
May 21, 2024
Eli Lilly's diabetes drug tirzepatide receives approval in China, intensifying competition with Novo Nordisk's Ozempic. This move signals a significant expansion in the Asian market, where GLP-1...
Via
Benzinga
3 S&P 500 Stocks to Buy in May Before They Rocket Higher
May 21, 2024
These three stocks sit on the precipice of huge, long-term gains, making them among the best to grab now before they soar.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections
May 20, 2024
HIMS stock is catching a bid after Hims & Hers announced that it would begin providing access to GLP-1 weight-loss injections.
Via
InvestorPlace
Magnificent Seven? Just Two Members Meet This Earnings Criteria
May 20, 2024
These megacaps meet triple-25% growth standards.
Via
Investor's Business Daily
Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market?
May 19, 2024
Eli Lilly's biggest growth drivers today are its weight loss drugs.
Via
The Motley Fool
EXCLUSIVE: GameStop, AMC Buzz 'May Prove To Be Short-Lived,' CEO Of Company Behind MEME ETF Tells Benzinga
May 17, 2024
The company behind the MEME ETF shares what it would take to bring the meme stock fund back to the market.
Via
Benzinga
Topics
ETFs
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.